Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

DSGNDSGN
Showing 8 of 22 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in DESIGN THERAPEUTICS INC

BAKER BROS. ADVISORS LP holds 2.7M shares of DSGN (DESIGN THERAPEUTICS INC), worth $38.8M as of 2026-Q2. The position was increased (+3.6% shares). DSGN represents 0.2% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$38.8M

Current Shares

2.7M

Total Value Change

+$29.4M

Total Shares Change

+934,705

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.7M
+3.6%
$38.8M0.2%$14.47
36
2026-Q1
Increased
2.6M
+15.8%
$27.5M0.2%$10.00
40
2025-Q4
Increased
2.2M
+30.4%
$20.9M0.1%$9.79
43
2025-Q3
Unchanged
1.7M
0.0%
$12.9M0.1%$6.85
0
2025-Q2
Decreased
1.7M
-1.8%
$5.8M0.1%$3.57
0
2025-Q1
Unchanged
1.7M
0.0%
$6.7M0.1%$4.21
0
2024-Q4
Unchanged
1.7M
0.0%
$10.8M0.1%$6.17
0
2024-Q3
Increased
1.7M
+2.9%
$9.4M0.1%$5.33
28

Other major holders of DSGN: CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used